Z-1561-2021Class II
Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package -
Remel Inc / initiated 2021-04-22 / Terminated
Remel Inc began a recall of Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage: use in qualitative procedures as a screening method for... on . FDA classified it as Class II and gives the reason as "The media allows growth of E. faecalis ATCC 29212 with blackening of the media". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-1561-2021
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Remel Inc
- Product
- Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage: use in qualitative procedures as a screening method for primary isolation and presumptive identification of vancomycin-resistance enterococci (VRE) from surveillance cultures.
- Product code
- JSO Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar
- Reason for recall
- The media allows growth of E. faecalis ATCC 29212 with blackening of the media.
- FDA root cause
- Mixed-up of materials/components
- Action
- The recalling firm issued customer letters dated 4/22/2021 via first class mail to its direct accounts.
- Quantity in commerce
- 91/10-test units
- Distribution
- US Nationwide distribution in the states of AZ, CA, CO, CT, GA, IA, IL, IN, MA, MI, MN, MO, NC, ND, OH, OR, PA, SD, TN, TX, and VA. There was government distribution and no military or foreign distribution.
- Product codes and lots
- Lot #248035, Exp. 2021-04-27
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1561-2021 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
